Lista de obras - Guido Alves - Dominio Público Uruguay

A 12-year population-based study of freezing of gait in Parkinson's disease

artículo científico publicado en 2014

A 12-year population-based study of psychosis in Parkinson disease

artículo científico publicado en 2010

A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells ⬇️

artículo científico publicado en 2015

A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease

scholarly article by Madeleine Kristiansen et al published February 2019 in Movement Disorders

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study

artículo científico publicado en 2009

Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease

artículo científico publicado en 2018

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

artículo científico publicado en 2009

Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population.

artículo científico publicado en 2015

Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease

artículo científico publicado en 2018

Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).

artículo científico publicado en 2009

CSF Aβ42 predicts early-onset dementia in Parkinson disease

artículo científico publicado en 2014

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies

artículo científico publicado en 2010

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

artículo científico publicado en 2010

Cellular Proteostasis in Neurodegeneration

scientific article published on 04 September 2018

Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease

artículo científico publicado en 2013

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

artículo científico publicado en 2012

Changes in motor subtype and risk for incident dementia in Parkinson's disease

artículo científico publicado en 2006

Cigarette smoking in Parkinson's disease: influence on disease progression

artículo científico publicado en 2004

Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study

artículo científico publicado en 2017

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

artículo científico publicado en 2008

Combinatory microRNA serum signatures as classifiers of Parkinson's disease

artículo científico publicado en 2019

Common gene expression signatures in Parkinson's disease are driven by changes in cell composition

scientific article published on 21 April 2020

Differences in the Presentation and Progression of Parkinson's Disease by Sex

artículo científico publicado en 2020

Differential transcript usage in the Parkinson's disease brain

artículo científico publicado en 2020

Disorders of motivation, sexual conduct, and sleep in Parkinson's disease

artículo científico publicado en 2005

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

artículo científico publicado en 2018

Epidemiology of Parkinson's disease

scientific article published on 01 September 2008

Epidemiology of psychosis in Parkinson's disease.

artículo científico publicado en 2009

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

artículo científico publicado en 2018

Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease

scientific article published on 18 October 2019

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection

article

Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?

artículo científico publicado en 2006

Familial Parkinson's disease: a community-based study

artículo científico publicado en 2003

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease

artículo científico publicado en 2010

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

artículo científico publicado en 2019

Genetic risk scores and hallucinations in patients with Parkinson disease

scientific article published on 20 July 2020

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain

artículo científico publicado en 2021

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

scientific article published on 10 September 2019

Gray matter correlations of cognition in incident Parkinson's disease

artículo científico publicado en 2010

Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment

artículo científico publicado en 2011

Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease

artículo científico publicado en 2018

Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study.

artículo científico publicado en 2016

Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden

artículo científico publicado en 2020

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

artículo científico publicado en 2009

Inflammation and fatigue in early, untreated Parkinson's Disease

artículo científico publicado en 2018

Is fatigue an independent and persistent symptom in patients with Parkinson disease?

artículo científico publicado en 2004

Is psychosis associated with impulse control disorders in Parkinson's disease?

artículo científico publicado en 2018

LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation

artículo científico publicado en 2016

Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.

artículo científico publicado en 2016

Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study.

artículo científico publicado en 2016

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

artículo científico publicado en 2009

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci

artículo científico publicado en 2020

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

artículo científico publicado en 2015

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study

artículo científico publicado en 2017

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome

artículo científico publicado en 2020

Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?

artículo científico publicado en 2017

Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage

artículo científico publicado en 2017

Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia

scientific article published on 01 August 2020

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

artículo científico publicado en 2008

New insight into neurodegeneration: the role of proteomics

artículo científico

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease

artículo científico publicado en 2018

Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study

artículo científico publicado en 2009

Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study

artículo científico publicado en 2019

Parkinson's disease and age: The obvious but largely unexplored link.

artículo científico publicado en 2014

Predictors and course of health-related quality of life in Parkinson's disease

artículo científico publicado en 2008

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study

artículo científico publicado en 2008

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned

artículo científico publicado en 2016

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

artículo científico publicado en 2013

Progression of fatigue in Parkinson's disease -A nine-year follow-up

scientific article published on 13 September 2020

Progression of motor impairment and disability in Parkinson disease: a population-based study

artículo científico publicado en 2005

Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease.

artículo científico publicado en 2012

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease

artículo científico publicado en 2018

Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's Disease

artículo científico publicado en 2020

Reliability of Three Disability Scales for Detection of Independence Loss in Parkinson's Disease

artículo científico publicado en 2016

Risk and course of motor complications in a population-based incident Parkinson's disease cohort

artículo científico publicado en 2015

Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.

artículo científico publicado en 2016

The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation.

artículo científico publicado en 2010

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease

artículo científico publicado en 2009

The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology

artículo científico publicado en 2019

Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease

artículo científico publicado en 2017

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid

artículo científico publicado en 2020

Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease

scientific article published on 30 May 2020

Validation of a new assay for α-synuclein detection in cerebrospinal fluid

artículo científico publicado en 2016

Ventricular enlargement and mild cognitive impairment in early Parkinson's disease

artículo científico publicado en 2010

Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

artículo científico

What predicts mortality in Parkinson disease?: a prospective population-based long-term study

artículo científico publicado en 2010

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease

artículo científico publicado en 2009

microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases

artículo científico publicado en 2015

Lista de obras de Guido Alves

A 12-year population-based study of freezing of gait in Parkinson's disease

A 12-year population-based study of psychosis in Parkinson disease

A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells ⬇️

A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study

Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population.

Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease

Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).

CSF Aβ42 predicts early-onset dementia in Parkinson disease

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

Cellular Proteostasis in Neurodegeneration

Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

Changes in motor subtype and risk for incident dementia in Parkinson's disease

Cigarette smoking in Parkinson's disease: influence on disease progression

Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Combinatory microRNA serum signatures as classifiers of Parkinson's disease

Common gene expression signatures in Parkinson's disease are driven by changes in cell composition

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Differential transcript usage in the Parkinson's disease brain

Disorders of motivation, sexual conduct, and sleep in Parkinson's disease

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

Epidemiology of Parkinson's disease

Epidemiology of psychosis in Parkinson's disease.

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

Evolution of impulsive-compulsive behaviors and cognition in Parkinson's disease

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection

Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?

Familial Parkinson's disease: a community-based study

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

Genetic risk scores and hallucinations in patients with Parkinson disease

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

Gray matter correlations of cognition in incident Parkinson's disease

Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment

Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease

Impulsive and Compulsive Behaviors in Parkinson's Disease: The Norwegian ParkWest Study.

Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

Inflammation and fatigue in early, untreated Parkinson's Disease

Is fatigue an independent and persistent symptom in patients with Parkinson disease?

Is psychosis associated with impulse control disorders in Parkinson's disease?

LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation

Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.

Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study.

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome

Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?

Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage

Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

New insight into neurodegeneration: the role of proteomics

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease

Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study

Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study

Parkinson's disease and age: The obvious but largely unexplored link.

Predictors and course of health-related quality of life in Parkinson's disease

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

Progression of fatigue in Parkinson's disease -A nine-year follow-up

Progression of motor impairment and disability in Parkinson disease: a population-based study

Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease.

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease

Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's Disease

Reliability of Three Disability Scales for Detection of Independence Loss in Parkinson's Disease

Risk and course of motor complications in a population-based incident Parkinson's disease cohort

Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.

The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation.

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease

The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology